Form 8-K · Current report
News Corp 8-K, filed Aug 14, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000180
Summary
News Corp repurchased 62,323 shares of its Class A common stock for about US$1.8 million on August 13, 2026, under its 2025 Repurchase Program authorizing up to US$1 billion of Class A and Class B stock. The company has spent roughly US$423.3 million on the program to date.
Key points
- The daily buy-back notification to the Australian Securities Exchange reported 62,323 Class A shares bought back on August 13, 2026, at a total consideration of US$1,798,024.78.
- Cumulative Class A repurchases reported in the notification total 10,721,345 shares for US$274,338,655.38.
- Prices paid in the most recent day's purchases ranged from US$28.39 to US$29.39; the highest price paid under the program was US$30.79 and the lowest US$22.20.
- Goldman Sachs & Co. LLC is named as broker, and News Corp states the buy-back's purpose is to enhance shareholder value.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.